Evidence map›Paper›PMID 32722247›Full record

ArticleCancers2020

TCGA mRNA Expression Analysis of the Heme Biosynthesis Pathway in Diffusely Infiltrating Gliomas: A Comparison of Typically 5-ALA Fluorescent and Non-Fluorescent Gliomas.

Mario Mischkulnig, Barbara Kiesel, Daniela Lötsch, Thomas Roetzer, Martin Borkovec, Lisa I Wadiura, Petra A Mercea, Florian J Jaklin, Shawn Hervey-Jumper, Karl Roessler and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 3 countries.

Mario MischkulnigDepartment of Neurosurgery, Medical University Vienna, 1090 Vienna, Austria.ORCID 0000-0001-5478-0792
Barbara KieselDepartment of Neurosurgery, Medical University Vienna, 1090 Vienna, Austria.ORCID 0000-0003-0939-9831
Daniela LötschDepartment of Neurosurgery, Medical University Vienna, 1090 Vienna, Austria.
Thomas RoetzerComprehensive Cancer Center-Central Nervous System Tumours Unit, Medical University Vienna, 1090 Vienna, Austria.ORCID 0000-0001-8875-7304
Martin BorkovecDepartment of Neurosurgery, Medical University Vienna, 1090 Vienna, Austria.
Lisa I WadiuraDepartment of Neurosurgery, Medical University Vienna, 1090 Vienna, Austria.
Petra A MerceaDepartment of Neurosurgery, Medical University Vienna, 1090 Vienna, Austria.
Florian J JaklinDepartment of Neurosurgery, Medical University Vienna, 1090 Vienna, Austria.
Shawn Hervey-JumperDepartment of Neurological Surgery, University of California, San Francisco, CA 94143, USA.
Karl RoesslerDepartment of Neurosurgery, Medical University Vienna, 1090 Vienna, Austria.
Mitchel S BergerDepartment of Neurological Surgery, University of California, San Francisco, CA 94143, USA.
Georg WidhalmDepartment of Neurosurgery, Medical University Vienna, 1090 Vienna, Austria.
Friedrich ErhartDepartment of Neurosurgery, Medical University Vienna, 1090 Vienna, Austria.
Comprehensive Cancer Center Vienna · ATMedical University of Vienna · ATUniversity of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

5-Aminolevulinic acid (5-ALA) is a fluorescent dye that after metabolization to Protoporphyrin IX (PpIX) by the heme biosynthesis pathway typically leads to visible fluorescence in WHO grade IV but not grade II gliomas. The exact mechanism for high PpIX levels in WHO grade IV gliomas and low PpIX levels in WHO grade II gliomas is not fully clarified. To detect relevant changes in mRNA expression, we performed an in-silico analysis of WHO grade II and IV glioma sequencing datasets provided by The Cancer Genome Atlas (TCGA) to investigate mRNA expression levels of relevant heme biosynthesis genes: Solute Carrier Family 15 Member 1 and 2 (SLC15A1 and SLC15A2), Aminolevulinate-Dehydratase (ALAD), Hydroxymethylbilane-Synthase (HMBS), Uroporphyrinogen-III-Synthase (UROS), Uroporphyrinogen-Decarboxylase (UROD), Coproporphyrinogen-Oxidase (CPOX), Protoporphyrinogen-Oxidase (PPOX), ATP-binding Cassette Subfamily B Member 6 (ABCB6)/G Member 2 (ABCG2) and Ferrochelatase (FECH). Altogether, 258 WHO grade II and 166 WHO grade IV samples were investigated. The mRNA expression levels showed significant differences in 8 of 11 examined genes between WHO grade II and IV gliomas. Significant differences in mRNA expression included increases of HMBS, UROD, FECH and PPOX as well as decreases of SLC15A2, ALAD, UROS and ABCB6 in WHO IV gliomas. Since the majority of changes was found in directions that might actually impair PpIX accumulation in WHO grade IV gliomas, additional studies are needed to analyze the corresponding factors of the heme biosynthesis also on protein level.

Indexed as

5-ALAfluorescencegene expressiongliomaheme biosynthesisTCGA

Identifiers

PMID32722247
PMCPMC7466145
OpenAlexW3043882256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.